Advaxis (ADXS) to Offer Common Stock

Go back to Advaxis (ADXS) to Offer Common Stock

Advaxis, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock

November 23, 2020 4:05 PM UTC

PRINCETON, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (the Company), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering. In connection with the offering, the Company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock and/or purchase warrants to purchase additional shares of... More